Boutron I - Search Results

1

A scoping review identifies multiple comments suggesting modifications to SPIRIT 2013 and CONSORT 2010.

Nejstgaard CH, Boutron I, Chan AW, Chow R, Hopewell S, Masalkhi M, Moher D, Schulz KF, Shlobin NA, Østengaard L, Hróbjartsson A. Nejstgaard CH, et al. Among authors: boutron i. J Clin Epidemiol. 2023 Mar;155:48-63. doi: 10.1016/j.jclinepi.2023.01.003. Epub 2023 Jan 18. J Clin Epidemiol. 2023. PMID: 36669708 Free article. Review.

2

A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus.

Boutron I, Moher D, Tugwell P, Giraudeau B, Poiraudeau S, Nizard R, Ravaud P. Boutron I, et al. J Clin Epidemiol. 2005 Dec;58(12):1233-40. doi: 10.1016/j.jclinepi.2005.05.004. Epub 2005 Oct 13. J Clin Epidemiol. 2005. PMID: 16291467

3

The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic review.

Jacquier I, Boutron I, Moher D, Roy C, Ravaud P. Jacquier I, et al. Among authors: boutron i. Ann Surg. 2006 Nov;244(5):677-83. doi: 10.1097/01.sla.0000242707.44007.80. Ann Surg. 2006. PMID: 17060758 Free PMC article. Review.

4

Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.

Boutron I, Estellat C, Guittet L, Dechartres A, Sackett DL, Hróbjartsson A, Ravaud P. Boutron I, et al. PLoS Med. 2006 Oct;3(10):e425. doi: 10.1371/journal.pmed.0030425. PLoS Med. 2006. PMID: 17076559 Free PMC article. Review.

5

Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.

Boutron I, Guittet L, Estellat C, Moher D, Hróbjartsson A, Ravaud P. Boutron I, et al. PLoS Med. 2007 Feb;4(2):e61. doi: 10.1371/journal.pmed.0040061. PLoS Med. 2007. PMID: 17311468 Free PMC article. Review.

6

Development and evaluation of a pedagogical tool to improve understanding of a quality checklist: a randomised controlled trial.

Fourcade L, Boutron I, Moher D, Ronceray L, Baron G, Ravaud P. Fourcade L, et al. Among authors: boutron i. PLoS Clin Trials. 2007 May 4;2(5):e22. doi: 10.1371/journal.pctr.0020022. PLoS Clin Trials. 2007. PMID: 17479163 Free PMC article.

7

Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.

Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P; CONSORT Group. Boutron I, et al. Ann Intern Med. 2008 Feb 19;148(4):W60-6. doi: 10.7326/0003-4819-148-4-200802190-00008-w1. Ann Intern Med. 2008. PMID: 18283201 Free article.

8

Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P; CONSORT Group. Boutron I, et al. Ann Intern Med. 2008 Feb 19;148(4):295-309. doi: 10.7326/0003-4819-148-4-200802190-00008. Ann Intern Med. 2008. PMID: 18283207 Free article.

9

Comparison of registered and published primary outcomes in randomized controlled trials.

Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Mathieu S, et al. Among authors: boutron i. JAMA. 2009 Sep 2;302(9):977-84. doi: 10.1001/jama.2009.1242. JAMA. 2009. PMID: 19724045

10

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Schulz KF, Altman DG, Moher D; CONSORT Group. Schulz KF, et al. BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332. BMJ. 2010. PMID: 20332509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters